Jason Gotlib

17PUBLICATIONS
114CO-AUTHORS
Predictive and prognostic markersMedical mycologyMajor global burdens of diseaseCardiology (incl. cardiovascular diseases)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Feb 24, 2026
Risk stratification of patients with TP53-mutated myeloproliferative neoplasms.

Benjamin Rolles, Cilomar Martins de Oliveira Filho, Nathan Fergusson

|Jan 15, 2025
Prognostic impact of expression of CD2, CD25, and/or CD30 in/on mast cells in systemic mastocytosis: a registry study of the European Competence Network on Mastocytosis.

Axel Rüfer, Henning Nilius, Olivier Hermine

|Mar 29, 2024
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.

William Shomali, Jason Gotlib

|Mar 13, 2024
Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee.

Donal P McLornan, Tomasz Czerw, Gandhi Damaj

|Jul 27, 2023
Next-Generation JAK2 Inhibitors for the Treatment of Myeloproliferative Neoplasms: Lessons from Structure-Based Drug Discovery Approaches.

Pramod C Nair, Jacob Piehler, Denis Tvorogov

|Oct 07, 2022
Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes.

Peter Valent, Amy D Klion, Florence Roufosse

Pageof 3

Frequent Collaborators

4 joint publications

Daniel J DeAngelo

4 joint publications

Peter Valent

4 joint publications

Tracy I George

3 joint publications

Andreas Reiter